TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Nova Eye Medical ( (AU:EYE) ) has provided an update.
Nova Eye Medical Limited has announced an upcoming webinar featuring Dr. Mahmoud A. Khaimi, a renowned glaucoma specialist, who will discuss the clinical advantages of the company’s iTrack Advance™ surgical device. This event highlights Nova Eye Medical’s commitment to advancing ophthalmic treatment technologies and may enhance the company’s industry positioning by showcasing the effectiveness of their minimally invasive glaucoma solutions to stakeholders and potential clients.
More about Nova Eye Medical
Nova Eye Medical Limited is a medical technology company that develops, manufactures, and sells a range of proprietary ophthalmic treatment technologies and devices. Their products, such as the iTrack™ Advance and Molteno3® glaucoma drainage device platform, are used globally by eye surgeons to treat glaucoma, aiming to restore the eye’s natural outflow pathway and enhance surgical outcomes. The company operates with sales headquarters in Fremont, California, and manufacturing facilities in both Fremont, California, and Dunedin, New Zealand.
YTD Price Performance: -18.75%
Average Trading Volume: 302,404
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$37.03M
Learn more about EYE stock on TipRanks’ Stock Analysis page.